MK800-62F1, a new inhibitor of apoptotic cell death, from Streptomyces diastatochromogenes MK800-62F1. I. Taxonomy, fermentation, isolation, physico-chemical properties and biological activity

Journal of Antibiotics

Volumn 53, Issue 6, 2000, Pages 569-574

  Yoshimoto, Yuya ^a   Sawa, Tsutomu ^b   Kinoshita, Naoko ^b   Homma, Yoshiko ^b   Hamada, Masa ^b   Takeuchi, Tomio ^b   Imoto, Masaya ^a  

^a KEIO UNIVERSITY   (Japan)

^b INSTITUTE OF MICROBIAL CHEMISTRY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFLAMMATORY AGENT; CAMPTOTHECIN; HYDROGEN PEROXIDE; MK 800 62F1; UNCLASSIFIED DRUG;

ANTIOXIDANT ACTIVITY; APOPTOSIS; ARTICLE; BACTERIUM CULTURE; CONTROLLED STUDY; DRUG ACTIVITY; DRUG ISOLATION; FERMENTATION; HUMAN; HUMAN CELL; LEUKEMIA CELL LINE; LUNG SMALL CELL CANCER; NONHUMAN; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; STREPTOMYCES; TAXONOMY;

STREPTOMYCES DIASTATOCHROMOGENES;

EID: 0033923737     PISSN: 00218820     EISSN: None     Source Type: Journal    
DOI: 10.7164/antibiotics.53.569     Document Type: Article

References (14)

1. STELLER, H.: Mechanisms and genes of cellular suicide. Science 267: 1445-1449, 1995
2. BERGMANN, A.; J. AGAPITE & H. STELLER: Mechanisms and control of programmed cell death in invertebrates. Oncogene 17: 3215-3223, 1998
3. THOMPSON, C. B.: Apoptosis in the pathogenesis and treatment of disease. Science 267: 1456-1462, 1995
4. MIZUNO, Y.; H. MOCHIZUKI, Y. SUGITA & K. GOTO: Apoptosis in neurodegenerative disorders. Intern. Med. 37: 192-193, 1998
5. HANNUN, Y. A.: Apoptosis and the dilemma of cancer chemotherapy. Blood 89: 1845-1853, 1997
6. SIMIZU, S.; M. TAKADA, K. UMEZAWA & M. IMOTO: Requirement of caspase-3(-like) protease-mediated hydrogen peroxide production for apoptosis induced by various anticancer drugs. J. Biol. Chem. 273: 26900-26907, 1998
7. YOSHIMOTO, Y.; T. SAWA, H. NAGANAWA, T. SUGAI, T. TAKEUCHI & M. IMOTO: MK800-62F1, a new inhibitor of apoptotic cell death, from Streptomyces diastatochromogenes MK800-62F1. II. Structural elucidation. J. Antibiotics 53: 575-578, 2000
8. SHIRLING, E. B. & D. GOTTLIEB: Methods for characterization of Streptomyces species. Int. J. Syst. Bacteriology 16: 313-340, 1966
9. WAKSMAN, S. A.: Classification, identification and descriptions of genera and species. In The Actinomycetes, Vol. II. pp. 1-363, The Williams & Wilkins Co., Baltimore, 1961
10. PRIDHAM, T. G. & D. GOTTLIEB: The utilization of carbon compounds by some Actinomycetales as an aid for species determination. J. Bacteriology 56: 107-114, 1948
11. BECKER, B.; M. P. LECHEVALIER, R. E. GORDON & H. A. LECHEVALIER: Rapid differentiation between Nocardia and Streptomyces by paper chromatography of whole-cell hydrolysates. Appl. Microbiol. 12: 421-423, 1964
12. TAMURA, K.; M. TAKADA, I. KAWASE, T. TADA, S. KUDOH, K. OKISHIO, M. FUKUOKA, N. YAMAOKA, Y. FUJIWARA & M. YAMAKIDO: Enhancement of tumor radio-response by irinotecan in human lung tumor xenografts. Jpn. J. Cancer Res. 88: 218-223, 1997
13. YOSHIKOSHI, M.; Y. YOSHIKI, K. OKUBO, J. SETO & Y. SASAKI: Prevention of hydrogen peroxide damage by soybean saponins to mouse fibroblasts. Planta Med. 62: 252-255, 1996
14. MACFARLANE, N. G.; D. J. MILLER, G. L. SMITH & D. S. STEELE: Effects of oxidants on the sarcoplasmic reticulum of saponin-treated rat ventricular trabecular trabeculae. Cardiovasc. Res. 28: 1647-1652, 1994